Kela reimbursement Agammaglobulinemia (D80-84)

No definition available.

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries KELA purch., KELA reimb.

KELA reimbursements: KELA codes 120

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector D3_KELA_IMMUDEF

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 137 86 51
Unadjusted prevalence (%) 0.05 0.06 0.05
Mean age at first event (years) 43.39 45.83 39.28

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Correlations

Index endpoint: D3_KELA_IMMUDEF – Kela reimbursement Agammaglobulinemia (D80-84)
GWS hits: 0

Survival analyses between endpoints

Plot

before Kela reimbursement Agammaglobulinemia (D80-84)
after Kela reimbursement Agammaglobulinemia (D80-84)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Kela reimbursement Agammaglobulinemia (D80-84)